Investing
250 Articles
These are the top analyst upgrades and downgrades featured by 24/7 Wall St. on Monday, October 13, 2014.
These are the top analyst upgrades, downgrades and initiations seen on Tuesday, October 7, 2014.
For many of the top biotech companies, orphan drugs have morphed into huge winners and have even generated other streams…
These are the top analyst upgrades and downgrades covered by 24/7 Wall St. on Friday, September 5, 2014.
ThinkstockA brand new research report from RBC highlights more than 50 biotech event catalysts that are on the horizon. These are…
In a new research report, UBS analysts are very positive on some top biotech stocks before second-quarter earnings numbers hit…
These are the top analyst upgrades, downgrades and initiations from Wall Street firms on Tuesday, July 8, 2014. They include…
These are the top Wall Street analyst upgrades, downgrades and initiations for Wednesday, June 25, 2014. They include Apple, Coach,…
Vertex Pharmaceuticals has reported that two Phase 3 studies of its lumacaftor cystic fibrosis drug in combination with its Kalydeco…
In a new report, the analysts at health care boutique Leerink highlight numerous upcoming catalysts for some top stocks in…
Here are the four top biotech names we found that all have hepatitis C drugs in their current pipelines at…
In a new research report, the pharmaceutical and biotech analysts at RBC highlight their meetings with a group of six…
ThinkstockIn just a matter of days, the S&P 500 managed to produce a sell-off of more than 6%. The equity…
Many bears on Wall Street say that biotech stocks are overvalued, but many trade in line with historical valuations. In…
Like many firms on Wall Street, the biotechnology team at UBS thinks that most of the top mega-cap and large…
Our top personal finance-related articles today. Your wallet will thank you later.